Yet Another Bulletin Board
Sponsored by: The Fans!


Welcome, Guest. Please Login or Register.
Nov 25th, 2024, 11:47pm

Upcoming Premiere Dates:
Survivor 23, Season premiere
Thursday, September 14 (8:00-9:30 PM, ET/PT) on CBS




Home Home Help Help Search Search Members Members Chat Chat Member Map Member Map Login Login Register Register

| Fantasy Survivor Game | Music Forums | The '80s Server Forums | Shop Online |



Metropolis Reality Forums « Arthritis drug Vioxx being pulled »

   Metropolis Reality Forums
   Off-Topic Forums
   In the News
(Moderators: lakelady, yesteach, MediaScribe, Bumper, Isle_be_back)
   Arthritis drug Vioxx being pulled
Previous topic | New Topic | Next topic »
Pages: 1  Reply Reply Add Poll Add Poll Notify of replies Notify of replies Send Topic Send Topic Print Print
   Author  Topic: Arthritis drug Vioxx being pulled  (Read 142 times)
lakelady
ForumsNet Moderator
Moderator
ForumsNet Member

*****






   
View Profile

Posts: 11251
Arthritis drug Vioxx being pulled
« on: Sep 30th, 2004, 10:57am »
Quote Quote Modify Modify

Arthritis drug Vioxx being pulled
Thursday, September 30, 2004 Posted: 9:59 AM EDT (1359 GMT)  
 
 
NEW YORK (Reuters) -- The arthritis drug Vioxx, used by millions of people around the world, is being pulled off the market after a study confirmed long-standing concerns that it raises the risk of heart attack and stroke, the manufacturer, Merck & Co., said today.
 
"Patients who are currently taking Vioxx should contact their health care providers to discuss discontinuing use of Vioxx and possible alternative treatments," Merck said.
 
The company said it was withdrawing the drug following a review of data from a three-year colon cancer trial.
 
"In this study, there was an increased relative risk for confirmed cardiovascular events, such as heart attack and stroke, beginning after 18 months of treatment in the patients taking Vioxx compared to those taking placebo," Merck said in a press release.
 
Worldwide sales of Vioxx totaled $2.55 billion last year. Since the introduction of the drug in 1999, 91 million Vioxx prescriptions have been written in the United States alone. The drug is sold in some countries under the name Ceoxx.
 
Merck shares plunged 15 percent in pre-market trading after the announcement. Shares of Pfizer Inc., which sells two rival arthritis drugs, rose 5 percent.
 
"It's a major blow for Merck," said Sena Lund, an analyst at Cathay Financial. "It was one of their five key drivers for future growth."
 
Vioxx sales have been flat in recent years amid safety concerns. Clinical trial data have shown the drug increased the incidence of blood clots tied to strokes and heart attacks.
 
A recent study by the U.S. Food and Drug Administration suggested patients taking Vioxx faced a 50 percent greater risk of heart attacks and sudden cardiac death than those taking Pfizer's Celebrex arthritis treatment.
 
Sales of the Pfizer arthritis drugs Celebrex and Bextra have steadily grown as doctors have turned to those drugs, which have not been linked to heart attack and stroke.
 
The colon cancer trial was designed to evaluate the effectiveness of the standard 25-milligram Vioxx dose in preventing recurrence of colon polyps. Such polyps sometimes become cancerous.
 
Vioxx was used in the colon cancer trial because some researchers theorize that inflammation, present in arthritis, may be linked to colon cancer.
 
Merck said the heart attacks and strokes were not spotted during the first 18 months of the trial but became apparent later.
 
"Given the availability of alternative therapies, and the questions raised by the data, we concluded that a voluntary withdrawal (of Vioxx) is the responsible course to take," Merck Chief Executive Officer Raymond Gilmartin said.
 
Vioxx and the two Pfizer drugs are designed to block inflammation and pain as effectively as standard nonsteroidal anti-inflammatory drugs such as aspirin and ibuprofen, while causing far fewer ulcers and gastrointestinal problems than the older treatments.
 
The newer medicines block a protein called Cox-2 that has been linked to inflammation.
 
Merck said it would continue to market Arcoxia, its newer Cox-2 treatment that is sold in 47 countries. Approval of Arcoxia in the United States has been delayed by concerns among U.S. regulators about whether it poses the same risk of heart attack and stroke as Vioxx.
 
 
IP Logged
Back to top
Pocket
ForumsNet Member
USA 
*****





   
View Profile

Posts: 1437
Re: Arthritis drug Vioxx being pulled
« Reply #1 on: Sep 30th, 2004, 1:32pm »
Quote Quote Modify Modify

Angry  This really bothers me....in fact my BP went up after seeing the news.   I've been taking Vioxx for 2-3 years now.   This news also makes me wonder about the other drugs in this class, such as Celebrex.
IP Logged
Back to top
luci
ForumsNet Member
USA 
*****






   
View Profile

Gender: female
Posts: 12045
Re: Arthritis drug Vioxx being pulled
« Reply #2 on: Sep 30th, 2004, 1:41pm »
Quote Quote Modify Modify

.....and this news is why I don't take any of them!  I'm too scared of drugs Shocked
IP Logged

"A friend is someone who knows the song in your heart and
can sing it back to you when you have forgotten the words."
Back to top
AoM
ForumsNet Member
USA 
*****





    Biomajorbeth
View Profile

Posts: 2277
Re: Arthritis drug Vioxx being pulled
« Reply #3 on: Sep 30th, 2004, 2:51pm »
Quote Quote Modify Modify

I took Vioxx for a little while, but if you look at the warning label on that sucker its enough to scare anyone.  Glad I only needed it for a week or two.  It's good that they are pulling it...
IP Logged
Back to top
Pages: 1  Reply Reply Add Poll Add Poll Notify of replies Notify of replies Send Topic Send Topic Print Print

Previous topic | New Topic | Next topic »

Metropolis Reality Forums » Powered by YaBB 1 Gold - SP 1.3.1!
YaBB © 2000-2003. All Rights Reserved.